Immunosenescence Correlates with Poor Outcome from PD-(L)1 Blockade but Not Chemotherapy in Non-Small Cell Lung Cancer (NSCLC)

被引：0

作者：

Ferrara, R. ^{[1
]}

Naigeon, M. ^{[2
]}

Auclin, E. ^{[3
]}

Duchemann, B. ^{[2
]}

Cassard, L. ^{[2
]}

Medhi, J. J. ^{[2
]}

Boselli, L. ^{[2
]}

Grivel, J. ^{[2
]}

Desnoyer, A. ^{[2
]}

Texier, M. ^{[2
]}

Mezquita, L. ^{[2
]}

Aboubakar, F. ^{[2
]}

Hendriks, L. ^{[4
]}

Planchard, D. ^{[2
]}

Caramella, C. ^{[5
]}

Remon, J. ^{[6
]}

Ngocamus, M. ^{[2
]}

Nicotra, C. ^{[2
]}

Proto, C. ^{[1
]}

Sangaletti, S. ^{[7
]}

Chaput, N. ^{[2
]}

Besse, B. ^{[2
]}

机构：

[1] Fdn Irccs Ist Nazl Tumori Milan, Thorac Oncol Unit, Milan, Italy

[2] Gustave Roussy, Villejuif, France

[3] Hop Europeen Georges Pompidou, Paris, France

[4] Gustave Roussy, Oncol, Villejuif, France

[5] Gustave Roussy Canc Campus, Dept Radiol, Villejuif, France

[6] Hosp Hm Delfos, Barcelona, Spain

[7] Fdn Irccs Ist Nazl Tumori, Milan, Italy

来源：

JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期

关键词：

Immunecheckpoint blockade; immunosenescence; NSCLC;

D O I：

10.1016/j.jtho.2019.08.934

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.04-31

引用

页码：S452 / S452

页数：1

共 50 条

[41] Mitomycin C enhanced the efficacy of PD-L1 blockade in non-small cell lung cancer
Min Luo
Fang Wang
Hong Zhang
Kenneth K. W. To
Shaocong Wu
Zhen Chen
Shaobo Liang
Liwu Fu
Signal Transduction and Targeted Therapy, 5
[42] Mitomycin C synergizes with PD-L1 blockade in treatment of non-small cell lung cancer
LUO Min
ZHANG Hong
WU Shao-cong
CHEN Zhen
LIANG Shao-bo
WANG Fang
FU Li-wu
中国药理学与毒理学杂志, 2019, (10) : 885 - 885
[43] Mitomycin C enhanced the efficacy of PD-L1 blockade in non-small cell lung cancer
Luo, Min
Wang, Fang
Zhang, Hong
To, Kenneth K. W.
Wu, Shaocong
Chen, Zhen
Liang, Shaobo
Fu, Liwu
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
[44] Resistance to PD-1/PD-L1 immune checkpoint blockade in advanced non-small cell lung cancer
Li, Lijun
Pu, Haihong
Zhang, Xiaoxin
Guo, Xiaotian
Li, Guangrui
Zhang, Minghui
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2025, 209
[45] Combination therapy with PD-1/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms
Huang, Mu-Yang
Jiang, Xiao-Ming
Wang, Bing-Lin
Sun, Yang
Lu, Jin-Jian
PHARMACOLOGY & THERAPEUTICS, 2021, 219
[46] Long-term responders to PD-1 blockade in patients with advanced non-small cell lung cancer (NSCLC).
Luo, Jia
Bandlamudi, Chaitanya
Ricciuti, Biagio
Vokes, Natalie
Schoenfeld, Adam Jacob
Egger, Jacklynn, V
Sauter, Jennifer L.
Plodkowski, Andrew J.
Preeshagul, Isabel Ruth
Kris, Mark G.
Van Allen, Eliezer Mendel
Taylor, Barry S.
Rizvi, Hira
Donoghue, Mark
Awad, Mark M.
Hellmann, Matthew David
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[47] Molecular correlates of PD-L1 expression in patients with non-small cell lung cancer.
Rizvi, Hira
Bandlamudi, Chaitanya
Schoenfeld, Adam Jacob
Sauter, Jennifer L.
Arbour, Kathryn Cecilia
Beras, Amanda
Egger, Jacklynn V.
Ladanyi, Marc
Donoghue, Mark
Rudin, Charles M.
Taylor, Barry S.
Hellmann, Matthew David
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[48] Genomic correlates and classification of PD-L1 status in non-small cell lung cancer.
Liang, Feng
Liu, Sisi
Jiang, Ya
Xu, Xiuxiu
Ou, Qiuxiang
Bao, Hua
Wu, Xue
Shao, Yang
Hu, Xingsheng
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[49] Clinicopathological and genomic correlates of PD-L1 expression in nonsquamous non-small cell lung cancer
Lamberti, Giuseppe
Spurr, Liam
Li, Yvonne
Ricciuti, Biagio
Recondo, Gonzalo
Umeton, Renato
Cherniak, Andrew
Meyerson, Matthew
Awad, Mark
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
[50] Non-Small Cell Lung Cancer, PD-L1, and the Pathologist
Kerr, Keith M.
Nicolson, Marianne C.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (03) : 249 - 254

← 1 2 3 4 5 →